Smart oxygen device aims to free lung patients from constant monitoring

NCT ID NCT07704567

First seen Jul 15, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests a lightweight, battery-powered device called MoblO2 that automatically adjusts oxygen flow to keep blood oxygen levels steady during activity. It is designed for people with COPD or interstitial lung disease who need supplemental oxygen when exerting themselves. The goal is to see if the device helps them be more active, use oxygen more efficiently, and improve their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MoblO2 device, a closed-loop oxygen delivery regulator that automatically adjusts oxygen flow based on pulse oximeter readings
What this could lead to
If successful, this device could make supplemental oxygen easier to use, reduce the need for constant monitoring, and improve quality of life for people with chronic lung disease.
What could go wrong
This is a small, early-stage study with 48 participants, so results may not apply to everyone. The device may not work as intended in all situations, and technical failures or battery issues could pose risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Jewish Health

    RECRUITING

    Denver, Colorado, 80206, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.